Biocentis
PrivateLast Round
Grant
Nov 19, 2025
Total Funding Raised
$6.91M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Biocentis is a biotechnology company that develops next-generation genetic technologies and AI-driven solutions for sustainable insect control to protect public health, agriculture, and biodiversity.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Environmental Monitoring
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biocentis Comparables
Compare Biocentis with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Synvect | 81% | |
| MosquitoMate, Inc. | 79% | |
| Agragene Inc | 79% | |
Biocentis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 19, 2025 | ||||
| Grant | Nov 27, 2023 | ||||
| Grant | Oct 14, 2023 | ||||
| Pre Seed | Feb 1, 2023 |
Biocentis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Neurone | Grant, Pre Seed |
| Corbites | Grant |
| The Grantham Foundation for the Protection of the Environment | Grant |
| Jeremy and Hannelore Grantham Environmental Trust | Grant |
| Italian Ministry of University and Research | Grant |
| Novaterra | Grant |
| Algebris Investments | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 19, 2025
$19M raised in Seed round.
- Oct 14, 2023
$445K grant round completed.
Biocentis Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Biocentis's valuation, stock price, and market status.